CLINICAL SUMMARY
AirPhysio Clinical Summary for Pulmonologists
A concise evidence and application summary for respiratory physicians.
Device
AirPhysio is an OPEP device (steel ball in a conical seat) delivering oscillating positive expiratory pressure for airway clearance and lung-volume expansion.
Indications Used
COPD, bronchiectasis, cystic fibrosis, asthma with mucus, atelectasis, post-TB and chronic-sputum conditions.
Evidence
- A real-world matched cohort of 810 COPD patients showed lower 30-day exacerbation and hospitalisation rates with an OPEP device versus standard care (Burudpakdee, 2017).
- Three to four weeks of OPEP improved MRI-measured ventilation, dyspnoea and 6-minute-walk distance in COPD with chronic sputum (Svenningsen, 2015).
- A systematic review and meta-analysis reported improved sputum clearance and symptom or quality-of-life outcomes with OPEP in COPD (2020).
- An independent Griffith University review (Prof. Norman Morris) validated the AirPhysio mechanism within established airway-clearance science.
Balanced View
A CF paediatric RCT reported greater FVC decline and hospitalisation with a flutter-type OPEP vs PEP - device selection and supervision matter.
Regulatory
AirPhysio is TGA-listed (Australia) and US FDA 510(k)-cleared (K203209); the manufacturer holds ISO 9001 and ISO 13485 quality certification (verify current validity).
Next step Request samples, an evidence pack, or a CPD session. Health Brands SA - tshepo@therapyonthego.co.za - airphysio.co.za.
Get AirPhysio® — R945 incl. 15% VAT
Drug-free airway clearance. Fulfilled by the official SA store.
This platform records measurements taken by your health practitioner and readings you self-report. It does not diagnose or treat any condition. AirPhysio® is a trademark of its manufacturer; claims are limited to airway clearance and lung-expansion support. Items requiring specialist confirmation are marked for review before external use.